ICD10BillableValid for clinical use

ICD-10 Code I77.82: Antineutrophilic cytoplasmic antibody [ANCA] vasculitis

I77.82 is a billable ICD-10 diagnosis code used to classify Antineutrophilic cytoplasmic antibody [ANCA] vasculitis in medical records and claims. You may see this code in hospital records, discharge summaries, insurance claims, encounter documentation, referrals, or other healthcare billing and coding records. ICD-10 codes are diagnosis classification codes used in healthcare records, reporting, coding workflows, and billing support. This code sits within the broader ICD-10 area for Diseases of the circulatory system (I00-I99).

What is this code?

ICD-10 codes are diagnosis classification codes used in healthcare records, reporting, coding workflows, and billing support. This code sits within the broader ICD-10 area for Diseases of the circulatory system (I00-I99).

đź“‹Clinical overview

ANCA-associated vasculitis involves inflammation of blood vessels and can affect different organs. ANCA is the name of a group of antibodies measured in blood, not a diagnosis by itself. Clinical findings and other investigations matter: some people have these antibodies without vasculitis, and an absent antibody result does not by itself settle the assessment. This entry does not identify a named subtype, affected organ or treatment plan.

When is it used?

  • May be used when a clinician documents antineutrophilic cytoplasmic antibody [anca] vasculitis in a patient's medical record.
  • May appear in hospital records, claims, referrals, and clinical documentation.
  • This code can be used as a clinically usable diagnosis entry in standardized coding workflows.

What it does not mean

  • A code alone does not explain severity, treatment plan, or outcome.
  • A medical code should not be treated as a substitute for a doctor's diagnosis or advice.

🩺Clinical context

When commonly used
  • Use depends on documented ANCA-associated or ANCA-positive vasculitis within the entry's scope, not merely a positive laboratory result. The clinician considers symptoms, examination and other evidence together.
  • Symptoms can differ between people and organs. Tiredness, rash, sinus symptoms or urinary changes alone do not establish this diagnosis, and the code does not mean that every organ described in a reference is affected.
  • General ANCA resources discuss named conditions such as GPA, MPA and EGPA. Those names are not interchangeable coding assignments here; follow the actual diagnosis and the preserved specific classification instructions.
  • Review the history, relevant medicines and any previous diagnosis with the team. The entry does not supply a drug-induced, infectious or inherited cause, demographic profile, disease duration or level of current activity.
Common workup
  • The clinician assesses symptoms and examines for possible vessel or organ involvement while considering other explanations. Tell the team about new breathing, eye, nerve, skin or urine changes rather than interpreting the code as a complete organ assessment.
  • Selected blood and urine testing may assess inflammation, kidney function and relevant antibodies. A positive result is not proof of organ damage, and a reassuring symptom history alone does not establish normal kidney function.
  • Imaging or a tissue biopsy may answer a specific clinical question. The entry does not order every scan, a kidney biopsy for everyone, a repeat antibody timetable or a diagnostic threshold; discuss what a proposed investigation would clarify.
  • Ask the team to explain the actual ANCA report alongside the clinical findings. A test pattern or changing antibody amount alone is not a home method for diagnosing a subtype, deciding disease activity or adjusting treatment.
Common management context
  • The care team tailors treatment to the actual diagnosis, activity, severity and any organ involvement. Controlling active inflammation and maintaining remission are different goals; this code alone cannot select a medicine or establish that disease is inactive.
  • Treatment may reduce immune activity and can increase infection risk. Discuss monitoring, possible adverse effects and when to seek help; the label supplies no universal steroid, immunosuppressant, antibiotic or vaccination regimen.
  • Do not start, stop or change prescribed treatment based only on an antibody result or this page. There is no automatic plasma-exchange, dialysis or transplant requirement, and possible treatments in a reference are not evidence that a person needs them.
  • Follow the individual review plan and report new or returning symptoms. Ask about support for daily life and any diet or activity advice relevant to the actual condition; there is no fixed follow-up interval, kidney diet, fluid target or promise of cure or lasting remission.

🔍Key distinctions

Important notes
  • Coughing up blood or severe new breathing difficulty needs emergency assessment. Report new eye or vision problems or a marked reduction in urine urgently; do not wait for a routine antibody test or follow-up appointment to assess these changes.
  • The title and ANCA-positive-vasculitis inclusion do not establish vasculitis from an antibody result alone. They do not assign kidney failure, lung bleeding, heart disease, neuropathy or an affected vessel to every person.
  • Keep the actual Excludes2 distinctions for EGPA, GPA and MPA and the broader category notes. These instructions are not a blanket coexistence prohibition, and the broad disease groups in patient references do not replace documented ICD-10-CM classification.
  • Existing coding, guidance, exclusions, relationships, tests, procedures and semantic suggestions remain intact. Echo/3D-rendering, limb-physiology and cervical-spine CT service links are not proof of heart, limb or spinal disease, investigation orders or procedure-eligibility decisions.
  • I77.82 is the billable ANCA-vasculitis leaf, not the I77.8 grouping or unspecified arteritis. Its two vasculitis inclusion terms retain their clinical-diagnosis context, and its existing aortic-ectasia and other-arterial-disorder navigation links are not additional diagnoses.
Important exclusions
  • eosinophilic granulomatosis with polyangiitis (M30.1)
  • granulomatosis with polyangiitis (M31.3-)
  • microscopic polyangiitis (M31.7)
Related codes to consider
I77.81Aortic ectasia
Existing arterial entry for navigation; ANCA vasculitis, aortic ectasia and other arterial disorders require their own documentation. A link is not a diagnosis, investigation or treatment order.
I77.89Other specified disorders of arteries and arterioles
Existing arterial entry for navigation; ANCA vasculitis, aortic ectasia and other arterial disorders require their own documentation. A link is not a diagnosis, investigation or treatment order.

Code hierarchy

chapter
9Diseases of the circulatory system (I00-I99)
block
I70-I79Diseases of arteries, arterioles and capillaries
category
I77Other disorders of arteries and arterioles
category
I77.8Other specified disorders of arteries and arterioles
currentI77.8

Official coding notes

Inclusion terms
  • ANCA associated vasculitis
  • ANCA positive vasculitis
Excludes2 (may code together if documented)
  • eosinophilic granulomatosis with polyangiitis (M30.1)
  • granulomatosis with polyangiitis (M31.3-)
  • microscopic polyangiitis (M31.7)

Where you may see this code

You may see this code in hospital records, discharge summaries, insurance claims, encounter documentation, referrals, or other healthcare billing and coding records.

Related specialists

CardiologistGeneral Physician

Coverage-related procedures and services

CPT 93978high
DUPLEX SCAN OF AORTA, INFERIOR VENA CAVA, ILIAC VASCULATURE, OR BYPASS GRAFTS; COMPLETE STUDY
Source: CMS coverage guidance
CPT 93979high
DUPLEX SCAN OF AORTA, INFERIOR VENA CAVA, ILIAC VASCULATURE, OR BYPASS GRAFTS; UNILATERAL OR LIMITED STUDY
Source: CMS coverage guidance
CPT 93975high
DUPLEX SCAN OF ARTERIAL INFLOW AND VENOUS OUTFLOW OF ABDOMINAL, PELVIC, SCROTAL CONTENTS AND/OR RETROPERITONEAL ORGANS; COMPLETE STUDY
Source: CMS coverage guidance
CPT 93976high
DUPLEX SCAN OF ARTERIAL INFLOW AND VENOUS OUTFLOW OF ABDOMINAL, PELVIC, SCROTAL CONTENTS AND/OR RETROPERITONEAL ORGANS; LIMITED STUDY
Source: CMS coverage guidance
CPT 93925high
DUPLEX SCAN OF LOWER EXTREMITY ARTERIES OR ARTERIAL BYPASS GRAFTS; COMPLETE BILATERAL STUDY
Source: CMS coverage guidance
CPT 93926high
DUPLEX SCAN OF LOWER EXTREMITY ARTERIES OR ARTERIAL BYPASS GRAFTS; UNILATERAL OR LIMITED STUDY
Source: CMS coverage guidance

Coding guidelines

Common synonyms

Antineutrophilic cytoplasmic antibody [ANCA] vasculitis

Frequently asked questions

Code details

CodeI77.82
SystemICD10
Display nameAntineutrophilic cytoplasmic antibody [ANCA] vasculitis
ChapterDiseases of the circulatory system (I00-I99)
BlockDiseases of arteries, arterioles and capillaries

Flags

BillableYes
Valid clinical useYes

Source

SourceICD-10
Version2026-annual
Releaseannual
Year2026

Index terms

Matched terms
VasculitisVasculitisVasculitis

About this content

This page is prepared by HealthAssure's clinical team using official coding standards from ICD-10. AI tools assist with drafting explanations, which are then reviewed and verified by healthcare professionals for accuracy. This content is for informational purposes and does not replace professional medical advice. Meet our team.